Evidence map›Paper›PMID 36593848›Full record

ArticleHeliyon2022

Photocatalytic remediation of methylene blue using hydrothermally synthesized H-Titania and Na-Titania nanotubes.

Aderemi Timothy Adeleye, Kingsley Igenepo John, Joshua O Ighalo, Samuel Ogunniyi, Comfort Abidemi Adeyanju, Adewale George Adeniyi, Mohammed Elawad, Martins O Omorogie

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 17 citations in OpenAlex.

  1. Synergistic photocatalysis of a hydrochar/CeOEnvironmental science and pollution research international · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Aderemi Timothy AdeleyeGlobal Centre for Environmental Remediation (GCER), The University of Newcastle, Callaghan, Australia.
Kingsley Igenepo JohnOrganization of African Academic Doctor (OAAD), Off Kamiti Road, P. O. Box 25305000100, Nairobi, Kenya.
Joshua O IghaloDepartment of Chemical Engineering, University of Ilorin, P. M. B. 1515, Ilorin, Nigeria.
Samuel OgunniyiDepartment of Chemical Engineering, University of Ilorin, P. M. B. 1515, Ilorin, Nigeria.
Comfort Abidemi AdeyanjuDepartment of Chemical Engineering, University of Ilorin, P. M. B. 1515, Ilorin, Nigeria.
Adewale George AdeniyiDepartment of Chemical Engineering, University of Ilorin, P. M. B. 1515, Ilorin, Nigeria.
Mohammed ElawadFaculty of Materials and Chemical Engineering, Yibin University, 64400, Yibin, China.
Martins O OmorogieDepartment of Chemical Sciences, Redeemer's University, P.M.B. 230, Ede, 232101, Nigeria.
University of Ilorin · NGAfrican Academy of Sciences · KEMurdoch University · AURedeemer's University · NGYibin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although nanotube is among the most effective morphology of Titania due to its unilateral pathway for photo-generated charge transfer and mechanical stability, its performance is still hampered by high recombination. In the present study, to further improve the photocatalytic degradation performance of Titania, univalent elements of H and Na were respectively ion-exchanged into the Titania nanotubes (TNTs). The photocatalyst was characterized using XRD, TEM, ICP-AES, and FTIR. The modified samples displayed enhanced photocatalytic degradation performance over Degussa TiO

Indexed as

Environmental protectionMethylene bluePhotocatalytic degradationTitania

Identifiers

PMID36593848
PMCPMC9803790
OpenAlexW4312221674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.